The Review article by Thomas and Limper on Pneumocystis pneumonia (PcP) published in Nature Reviews Microbiology illustrates the biological insights that have been gained from the use of molecular tools and the more recent technique of observation 1 . In this Correspondence, we discuss recent findings concerning the prevalence of trichomonads in the lungs of patients in different clinical contexts, including PcP.
The examination of bronchoalveolar lavage fluid (BALF) samples taken from patients with PcP at low magnification frequently detects cells that are not of human origin (FIG. 1) . By using molecular and immunological methods, these cells have been identified as belonging to the trichomonad group of protozoa (FIG. 2) . These microorganisms multiply in alveoli and are found in BALF without oral or upperrespiratory-tract-fluid contamination. Furthermore, there is a strong correlation between the abundance of Pneumocystis organisms and trichomonad populations. It is established that Trichomonas tenax, a commensal of the human oral cavity, occurs in bronchial secretions during chronic respiratory conditions 2, 3 . However, in the course of PcP, additional trichomonad species have been identified using molecular methods. These species include Trichomonas vaginalis, which is frequently found in the urogenital tract of humans 4 and Tritrichomonas foetus, a genital trichomonad that is found in bovids 5 .
The recent observation of trichomonads in BALF samples during the course of acute respiratory distress syndrome (ARDS) suggests that, unlike other opportunistic infectious agents, the development of trichomonads in lungs is not directly linked to immunosuppression 6 . It is likely that PcP and ARDS generate similar local hypoxic conditions that favour the colonization and growth of microaerophilic trichomonads. Superinfection by trichomonads during PcP could, therefore, be a secondary event within alveolar lumina that has been obliterated by fungal pathogens; drugs active against PcP have consistently cured patients of pulmonary trichomonosis 4, 5 . From our numerous observations, trichomonads are frequently -if not always -found in the BALF samples of PcP patients 7 . Thus, the common disease called PcP, which is attributed exclusively to the extensive proliferation of Pneumocystis organisms, could, in fact, be a more complex process that involves trichomonad co-infection. By considering PcP as a co-infection, all the events that occur in alveoli, which until now have been attributed only to Pneumocystis, may have to be reconsidered. In BALF samples, trichomonads appear as amoeboid cells. Transformation into the amoeboid form results from the interaction of trichomonads with host cells, which causes cytoskeletal changes, flagellum loss and the acquisition of pseudopodia. These amoeboid forms are deleterious to epithelial cells in vitro 8, 9 . Moreover, T. vaginalis and T. foetus have been shown to be pathogenic to humans and bovids, respectively, and are able to induce apoptosis in epithelial cells and macrophages [10] [11] [12] . In addition, trichomonads are frequently observed in close contact with alveolar macrophages in BALF samples, which suggests that there is a direct interaction with host innate immune defences.
Together, these observations suggest that trichomonads have a potential pathogenic effect on the alveolar epithelium during the course of PcP disease. even if the consequences of this parasitic superinfection remain hypothetical, the presence of trichomonads in the lungs of patients with PcP should not be considered to be merely anecdotal, and more attention should be given to these parasites. 
